Home Blog Page 233

Blog

Pharma Marketing Blog

Random

Doctors (and Patients) were Smarter than Exubera Marketers

Pharma Guy - April 9, 2008

Nice Try, Daiichi!

Pharma Guy - January 23, 2007

IOM Report Calls for DTC Moratorium

Pharma Guy - September 25, 2006

Paula Deen & Victoza: Brilliant or Dumb?

Pharma Guy - January 28, 2012

Science, College Undergrads Agree: Adderall is Da Bomb for Performance Enhancement!

Pharma Guy - April 27, 2009

Pharma Twitter Pioneers: A Snapshot

Pharma Guy - October 28, 2013

Optimizing User Experience: Design Principles for Pharma Websites

Claudia Barbiero - October 15, 2023

Parallels Between BP and J&J

Pharma Guy - May 28, 2010

Is Type 2 Diabetes Drug Marketing Responsible for Misdiagnosis of Type...

Pharma Guy - August 8, 2012

Ad Execs Not Viewed as Innovative By Americans Says AstraZeneca Survey

Pharma Guy - December 9, 2010

1...232233234...241 Page 233 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026